IN191311B - - Google Patents

Info

Publication number
IN191311B
IN191311B IN48MU2000DA IN191311B IN 191311 B IN191311 B IN 191311B IN 48MU2000D A IN48MU2000D A IN 48MU2000DA IN 191311 B IN191311 B IN 191311B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Susan Jane Corvari
Joseph Richard Creekmore
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of IN191311B publication Critical patent/IN191311B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN48MU2000D 1997-12-18 2000-05-31 IN191311B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IN191311B true IN191311B (hu) 2003-11-22

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
IN48MU2000D IN191311B (hu) 1997-12-18 2000-05-31

Country Status (30)

Country Link
US (1) US6399104B1 (hu)
EP (1) EP1041966B1 (hu)
JP (1) JP2001526206A (hu)
KR (1) KR20010033206A (hu)
CN (1) CN1282244A (hu)
AR (1) AR017884A1 (hu)
AT (1) ATE243999T1 (hu)
AU (1) AU744326C (hu)
BR (1) BR9813666A (hu)
CA (1) CA2313163A1 (hu)
DE (1) DE69816124T2 (hu)
DK (1) DK1041966T3 (hu)
EE (1) EE04260B1 (hu)
ES (1) ES2202915T3 (hu)
GB (1) GB9726735D0 (hu)
HU (1) HUP0004669A3 (hu)
ID (1) ID25857A (hu)
IL (1) IL136501A0 (hu)
IN (1) IN191311B (hu)
MY (1) MY133096A (hu)
NO (1) NO20003141L (hu)
NZ (1) NZ504566A (hu)
PL (1) PL341736A1 (hu)
PT (1) PT1041966E (hu)
RU (1) RU2205006C2 (hu)
SK (1) SK9402000A3 (hu)
TR (1) TR200001713T2 (hu)
UA (1) UA62991C2 (hu)
WO (1) WO1999032082A2 (hu)
ZA (1) ZA9811532B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
PT2054040E (pt) * 2006-08-16 2011-06-30 Novartis Ag Método para produzir dispersões sólidas de compostos terapêuticos altamente cristalinos
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
BR112019015721A2 (pt) 2017-01-30 2020-03-24 Western New England University Inibidores de tiol isomerases e uso dos mesmos
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
CN117999074A (zh) 2021-05-19 2024-05-07 奎尔塞斯制药股份公司 用于治疗肌萎缩侧索硬化症的含有槲皮素的组合物
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
PT1041966E (pt) 2003-11-28
WO1999032082A3 (en) 1999-09-16
DK1041966T3 (da) 2003-10-06
ZA9811532B (en) 1999-06-18
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
AR017884A1 (es) 2001-10-24
MY133096A (en) 2007-10-31
KR20010033206A (ko) 2001-04-25
NZ504566A (en) 2002-10-25
NO20003141D0 (no) 2000-06-16
EE200000330A (et) 2001-08-15
HUP0004669A3 (en) 2005-03-29
IL136501A0 (en) 2001-06-14
ATE243999T1 (de) 2003-07-15
DE69816124D1 (de) 2003-08-07
CA2313163A1 (en) 1999-07-01
AU744326C (en) 2002-11-07
RU2205006C2 (ru) 2003-05-27
EP1041966A2 (en) 2000-10-11
US6399104B1 (en) 2002-06-04
AU744326B2 (en) 2002-02-21
BR9813666A (pt) 2000-10-10
CN1282244A (zh) 2001-01-31
JP2001526206A (ja) 2001-12-18
EP1041966B1 (en) 2003-07-02
EE04260B1 (et) 2004-04-15
NO20003141L (no) 2000-06-16
DE69816124T2 (de) 2004-05-06
WO1999032082A2 (en) 1999-07-01
PL341736A1 (en) 2001-05-07
AU1571199A (en) 1999-07-12
SK9402000A3 (en) 2001-01-18
TR200001713T2 (tr) 2000-10-23
GB9726735D0 (en) 1998-02-18
ES2202915T3 (es) 2004-04-01
UA62991C2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
DE69839117D1 (hu)
ITMI971348A0 (hu)
IN191899B (hu)
JP2001515958A5 (hu)
IN191311B (hu)
ITMI971179A0 (hu)
BE2013C047I2 (hu)
ITPE970012V0 (hu)
ITRM970115V0 (hu)
ITGE970047A0 (hu)
ITRM970427A0 (hu)
IN185087B (hu)
ITTO970497A0 (hu)
ITTR970005V0 (hu)
CN3058088S (hu)
CN3057614S (hu)
CN3058533S (hu)
CN3058531S (hu)
CN3058462S (hu)
CN3058449S (hu)
CN3058984S (hu)
CN3058320S (hu)
CN3058269S (hu)
CN3058162S (hu)
IL127020A0 (hu)